Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

BP and Adnoc agree Egyptian joint venture

(Sharecast News) - BP has agreed a new joint venture in Egypt with long-standing partner Adnoc, it was confirmed on Wednesday. Under the deal, BP will contribute its gas interests in three development concessions in the country, as well as exploration agreements. The Abu Dhabi-based firm will make a "proportionate" cash contribution, which will be used for future growth opportunities.

Once complete, BP will own 51% and Adnoc, which is wholly owned by Emirate of Abu Dhabi, will control the remaining 49%.

William Lin, executive vice president of regions, corporates and solutions at BP, said: "This dynamic JV offers a platform for international growth that advances our long-standing and strategic partnership with Adnoc that spans over five decades."

Musabbeh Al Kaabi, executive director at Adnoc, said the deal was a "significant step forward" in building the firm's international natural gas portfolio.

He continued: "This progressive joint venture partnership will enhance Egyptian energy security and the economic potential of the region's most populous Arab country."

The formation of the joint venture, which is subject to regulatory approval, is expected to complete in the second half of 2024. Financial details were not disclosed.

As at 1015 GMT, shares in BP were unchanged at 480p.

Share this article

Related Sharecast Articles

Sirius Real Estate ups dividend as profits jump 32%
(Sharecast News) - Profits at business and industrial parks developer Sirius Real Estate surged by nearly a third in the year ended 31 March, helping the company to increase dividends for the tenth straight year.
GSK to appeal Delaware ruling on jury trials in Zantac cancer cases
(Sharecast News) - Pharma giant GSK said it would be appealing against a US court decision allowing jury trials in cases brought by cancer sufferers claiming its heartburn drug caused their condition.
AstraZeneca's lung cancer treatment recommended for approval in EU
(Sharecast News) - AstraZeneca has announced that its Tagrisso treatment for advanced lung cancer, when combined with chemotherapy, has been recommended for approval by European regulators.
China manufacturing PMI ticks up more than expected - Caixin
(Sharecast News) - Activity in China's manufacturing sector grew in May at the fastest rate in two years, according to data released on Monday.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.